Sidorenko, V., Scodeller, P., Uustare, A., Ogibalov, I., Tasa, A., Tshubrik, O., Salumäe, L., Sugahara, K. N., Simón-Gracia, L., & Teesalu, T. (2024). Targeting vascular disrupting agent-treated tumor microenvironment with tissue-penetrating nanotherapy. Scientific Reports, 14(1). https://doi.org/10.1038/s41598-024-64610-7

Nguyen, T. T. T., Greene, L. A., Mnatsakanyan, H., & Badr, C. E. (2024). Revolutionizing Brain Tumor Care: Emerging Technologies and Strategies. Biomedicines, 12(6), 1376. https://doi.org/10.3390/biomedicines12061376

Bupathi, M., Wang, J. S., Hu-Lieskovan, S., Piha-Paul, S. A., Chmielowski, B., Garmezy, B., Najjar, Y. G., Stein, M. N., Yao, L., Kanodia, J., Clynes, R., McGovern, P., & Thompson, B. (2023). 764 A phase 1, first-in-human (FIH), open-label, dose-finding and expansion study of XmAb808, a B7H3 x CD28 bispecific antibody, in combination with pembrolizumab in patients with advanced solid tumors. Regular and Young Investigator Award Abstracts. https://doi.org/10.1136/jitc-2023-sitc2023.0764

Parikh, S., Zeller, T., Shishehbor, M., Werner, M., Brodmann, M., Parise, H., Holden, A., Lichtenberg, M., Kashyap, V., Pietras, C., Tirziu, D., Ardakani, S., Beschorner, U., Krishnan, P., Niazi, K., Wali, A., & Lansky, A. (2022). TCT-209 Chocolate Touch Versus Lutonix Drug-Coated Balloon for Femoropopliteal Lesions in Patients With Diabetes Mellitus: Results of the Randomized Chocolate Touch Study. Journal of the American College of Cardiology, 80(12), B84. https://doi.org/10.1016/j.jacc.2022.08.246